2004
DOI: 10.1182/blood-2004-02-0655
|View full text |Cite
|
Sign up to set email alerts
|

Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

34
472
2
2

Year Published

2005
2005
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 515 publications
(512 citation statements)
references
References 26 publications
34
472
2
2
Order By: Relevance
“…Results revealed a positive induction within 7 days, demonstrated by staining of cartilage-specific proteogylcans. A mean cellular iron content of 24 pg was found in co-labeled MSC, this finding was similar to reported values for magnetic cell labeling without toxic effects [10,41,43]. Therefore, it was assumed that the co-labeling approach described above was an applicable method to study MSC in-vivo by MRI and to validate their localization by histology.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…Results revealed a positive induction within 7 days, demonstrated by staining of cartilage-specific proteogylcans. A mean cellular iron content of 24 pg was found in co-labeled MSC, this finding was similar to reported values for magnetic cell labeling without toxic effects [10,41,43]. Therefore, it was assumed that the co-labeling approach described above was an applicable method to study MSC in-vivo by MRI and to validate their localization by histology.…”
Section: Discussionsupporting
confidence: 82%
“…Another important issue was the differentiation capacity of co-labeled MSC. Different studies have shown that osteogenic and adipogenic differentiation of MSC is not affected by magnetic labeling, but considering contradictory results for chondrogenic differentiation [41,42], this seems to be sensitive to cellular iron uptake. Therefore, the chondrogenic differentiation capacity was investigated for co-labeled MSC.…”
Section: Discussionmentioning
confidence: 95%
“…However, combinations of new approaches using complementarity region (CDR3) size spectratyping and high-resolution magnetic imaging using T cells labeled with physiologically inert nanoparticles should enable studies of adoptively transferred T cells in the absence of genetic marking. 56,[59][60][61] Therapeutic acceleration of T-cell recovery after SCT A number of promising strategies involving adoptive cell therapy are being explored in the setting of SCT. T-cell subsets are perturbed for months to years after SCT, 62 and the T-cell repertoire as assessed by CDR3 spectratyping is constricted and unstable after SCT.…”
Section: Engraftmentmentioning
confidence: 99%
“…Although they provide less contrast enhancement per particle compared with SSPIO and MPIO, large numbers of particles can be loaded into each cell [18,19]. As cationic surfaces have been shown to facilitate cellular internalization [20,21], USPIO are often modified with polycationic cell permeating peptides (CPP) such as HIV transactivator (TAT) [22] or protamine [23]. Other transfection techniques, sometimes in concert with CPPs, are also used [24,25].…”
Section: Introductionmentioning
confidence: 99%